Matthew Kamps is a skilled IP litigator at Husch Blackwell LLP, focused on pharma patent litigation. Kamps has experience as a first-chair trial lawyer representing some of the largest pharma companies in the US in ANDA litigations, as well as being a vital player in multiple ITC litigations and post-grant proceedings for other pharma clients.
Legal 500 Editorial commentary

Accolades

Chicago Elite

Key clients

  • Nanjing Noratech Pharmaceuticals Co., Ltd
  • Handa Pharma, Inc.

Work highlights

Defended Nanjing Noratech Pharmaceutical Co., Ltd. in a five-day bench trial involving patents concerning multibillion dollar blockbuster drug ENTRESCO.